Prism Medico and Pharmacy Limited Schedules Board Meeting for February 13, 2026 to Consider Q3FY26 Financial Results
Published on: Feb. 7, 2026, 11:42 p.m. | Source: scanx.trade
Prism Medico and Pharmacy Limited has scheduled a board meeting for February 13, 2026, at 01:00 P.M. at its registered office in Himachal Pradesh to consider and approve Q3FY26 unaudited standalone financial results for the quarter ended December 31, 2025. The meeting agenda includes reviewing financial results with Limited Review Report as per SEBI Regulation 33 and discussing routine business matters. The company has notified both BSE (scrip code: 512217) and MSEI (symbol: PRISMMEI) in compliance with regulatory requirements.
